DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis

Information source: Instituto Palacios
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Candidiasis, Vulvovaginal

Intervention: Clotrimazole (Other)

Phase: Phase 4

Status: Completed

Sponsored by: Instituto Palacios


To determine proportion of women achieving clinical and mycological cure or have recurrences / reinfection after being treated for an acute episode of vulvovaginal candidiasis.

Clinical Details

Official title: Epidemiological Study About the Clinical and Microbiological Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis.

Study design: Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Primary outcome:

Vaginal swab test

Vaginal swab test

Vaginal swab test

Vaginal swab test


Minimum age: 18 Years. Maximum age: 50 Years. Gender(s): Female.


Inclusion Criteria:

- Sexually active women between 18 and 50 years

- Patients attending to the gynecologist with acute vulvovaginal candidiasis.

- Patients requiring standard treatment with clotrimazole 500 single dose and that the

decision to prescribe this treatment is prior to inclusion in the study.

- Women who agree to participate in the study and has signed the informed consent

sheet. Exclusion Criteria:

- Use of any medication that may interfere significantly with study assessments.

- Pregnant or breastfeeding

- Women with signs of other genital infection

- Within 3 months after childbirth or abortion

- Patients that is expected not to attend follow-up visits

Locations and Contacts

Instituto Palacios, Madrid 28009, Spain
Additional Information

Starting date: June 2013
Last updated: March 24, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017